Testosterone replacement therapy (TRT) has long been used for young men with organic hypogonadism, but its increasing use in older men with age-related testosterone decline has raised concerns about cardiovascular (CV) risk. Some studies suggest TRT may elevate the risk of cardiovascular disease (CVD), leading to FDA warnings, though no
